Research Use Only — Not for Human Consumption. This compound is sold exclusively for in vitro laboratory research by qualified professionals.
TIRZ-30
Tirzepatide 30 mg
TIRZ-30 provides 30 mg of tirzepatide (≥99.1% purity) as a lyophilized powder. Ideal for medium-duration animal studies or multi-dose dose-response experiments. Tirzepatide's dual mechanism produces measurable effects on pancreatic beta-cell function, hepatic glucose output, and adipocyte lipid metabolism. For research use only — not for human consumption.
Third-Party Tested. Every Lot.
Every batch of TIRZ-30 undergoes independent HPLC and mass spectrometry analysis through an accredited third-party laboratory before it is released for sale. No exceptions. No internal-only certificates.
RP-HPLC Analysis
Every lot measured by reverse-phase HPLC. TIRZ-30 consistently achieves 99.1%+ purity across batches.
ESI Mass Spec
Electrospray ionization mass spectrometry confirms exact molecular weight and rules out structural isomers or impurities.
Lot-Specific CoA
Your Certificate of Analysis references your exact lot number with actual chromatogram data — not a generic template.
Theoretical Research Analysis
All research information below reflects published preclinical literature only. This product is not for human use, consumption, or clinical application of any kind.
The 30 mg format is the most commonly used tirzepatide quantity in published rodent model studies, providing sufficient material for a full chronic dosing protocol at standard research doses.
Sequence Information
Amino acid sequence:
Y-Aib-EGTFTSDYSIALDK(C₁₈ diacid)AQAAK(GIP motif)EFIAWLVKGRMolecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4813.46 g/mol
You May Also Like
View allTIRZ-60
Tirzepatide 60 mg
TIRZ-10
Tirzepatide 10 mg
Semaglutide 20mg
Semaglutide 20 mg — GLP-1 Agonist
SEMA-10
Semaglutide 10 mg